Tumefactive multiple sclerosis. A rare but serious variable in multiple sclerosis Tumefactive multiple sclerosis. A rare but serious variable in multiple sclerosis

Tumefactive multiple sclerosis is a rare variant of multiple sclerosis, characterized by the presence of brain lesions that may be solitary or multiple. Considering that these lesions have a pseudotumoral appearance, it is a challenge to differentiate them from central nervous system neoplasms through neuroimaging. Many cases are associated with the administration of monoclonal antibodies, and due to an increase in the incidence of cancer globally, it is expected that secondary to chemotherapeutic treatments, more and more cases may appear. Taking into account the the of to review aspects of usefulness in clinical practice, on the diagnosis and approach of condition

[1]  B. Ray,et al.  Tumefactive Demyelination: A Clinico-Radiological Dilemma , 2021, The journal of the Royal College of Physicians of Edinburgh.

[2]  T. Hardy,et al.  Tumefactive demyelination: updated perspectives on diagnosis and management , 2021, Expert review of neurotherapeutics.

[3]  Alexis Rafael Narvaez-Rojas,et al.  Evidence-based medicine in neurosurgery: why and how? , 2021, Journal of neurosurgical sciences.

[4]  I. D. Lozada Martínez,et al.  Research career in neurosurgery: a challenge for future neurosurgeons. , 2021, Journal of neurosurgical sciences.

[5]  H. Varma,et al.  Prognostic factors in Tumefactive demyelinating lesions: A retrospective study , 2021, Journal of the Neurological Sciences.

[6]  M. Ortega-Sierra,et al.  Neuroeducation and neurorehabilitation in the neurosurgical patient: programs to be developed in Latin America and the Caribbean. , 2021, Journal of neurosurgical sciences.

[7]  H. French Tumefactive multiple sclerosis versus high-grade glioma: A diagnostic dilemma , 2021, Surgical neurology international.

[8]  J. R. García,et al.  A false-positive case on brain 18F-Choline PET/MR due to tumefactive multiple sclerosis. A case report. , 2021, Revista espanola de medicina nuclear e imagen molecular.

[9]  L. Moscote-Salazar,et al.  Letter: Need and Impact of the Development of Robotic Neurosurgery in Latin America. , 2021, Neurosurgery.

[10]  L. Moscote-Salazar,et al.  Letter to the Editor. Creating the conditions for gender equality to end sexual harassment in neurosurgery. , 2021, Journal of neurosurgery.

[11]  L. Moscote-Salazar,et al.  Simulation as a tool to educate the patient about neurosurgical pathology. , 2021, Journal of neurosurgical sciences.

[12]  Xiang Fang,et al.  Tumefactive multiple sclerosis (TMS): A case series of this challenging variant of MS. , 2020, Multiple sclerosis and related disorders.

[13]  V. Tomassini,et al.  Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study , 2020, European journal of neurology.

[14]  W. Tobin,et al.  Cyclophosphamide in treatment of tumefactive multiple sclerosis. , 2020, Multiple sclerosis and related disorders.

[15]  N. Adeeb,et al.  Tumefactive Multiple Sclerosis of the Cervical Spinal Cord: A Rare Case Report , 2020, Cureus.

[16]  Y. Shiio,et al.  Tumefactive multiple sclerosis which initially presented with brainstem encephalitis with a long-term follow-up. , 2019, Multiple sclerosis and related disorders.

[17]  A. Ajmeri,et al.  Tumefactive Multiple Sclerosis, A Rare Variant Presenting as Multiple Ring-enhancing Lesions in an Immunocompetent Patient: A Case Report , 2018, Cureus.

[18]  M. Cirillo,et al.  A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings , 2016, Medicine.

[19]  C. Marini,et al.  Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis , 2016, Neurological Sciences.

[20]  M. Cameron,et al.  Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders , 2016, Current Neurology and Neuroscience Reports.

[21]  A. Degnan,et al.  Neuroimaging of tumefactive multiple sclerosis with atypical features , 2015, Radiology case reports.

[22]  Sherif Hamed Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions. , 2015, World journal of clinical cases.

[23]  A. Lagares,et al.  Tumefactive multiple sclerosis requiring emergency craniotomy: case report and literature review. , 2013, Neurocirugia.

[24]  Ching-Piao Tsai,et al.  Tumefactive Multiple Sclerosis in Taiwan , 2013, PloS one.

[25]  K. Yamazaki,et al.  Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report , 2012, Journal of Medical Case Reports.

[26]  N. Souayah,et al.  Tumefactive Multiple Sclerosis presenting as Acute Ischemic Stroke. , 2011, Journal of vascular and interventional neurology.

[27]  N. Kettner,et al.  Tumefactive multiple sclerosis: an uncommon diagnostic challenge. , 2011, Journal of chiropractic medicine.

[28]  M. Uchino,et al.  Tumefactive multiple sclerosis. , 2009, Internal medicine.

[29]  Y. Shimizu,et al.  Correlation between Magnetic Resonance Imaging Findings and Pathological Observations in Tumefactive Multiple Sclerosis , 2009, The neuroradiology journal.

[30]  W. Brück,et al.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis , 2008, Brain : a journal of neurology.

[31]  N. Parvaneh,et al.  Tumefactive Multiple Sclerosis Variants: Report of Two Cases of Schilder and Balo Diseases , 2017, Iranian journal of child neurology.

[32]  A. Kurne,et al.  Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center. , 2013, Turkish neurosurgery.